Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function.

Keywords : ['inflammation oxidative stress insulin resistance', 'randomise control study effect', 'type diabete', 'endothelial function', 'different dose', 'aspirin']
Author : Fist_Author_Year_PM
4

Effect of oral vitamin D supplementation on glycemic control in patients with type 2 diabetes mellitus with coexisting hypovitaminosis D: A parellel group placebo controlled randomized controlled pilot study.

Keywords : ['parellel group placebo control randomize control pilot study', 'type diabetes mellitus', 'glycemic control', 'oral vitamin', 'coexist hypovitaminosis', 'supplementation', 'patient', 'effect']
Author : Fist_Author_Year_PM
4

Effect of a Dual PPAR alpha/gamma agonist on Insulin Sensitivity in Patients of Type 2 Diabetes with Hypertriglyceridemia- Randomized double-blind placebo-controlled trial.

Keywords : ['hypertriglyceridemia randomize doubleblind placebocontrolle trial', 'dual ppar alphagamma agonist', 'type diabete', 'insulin sensitivity', 'patient', 'effect']
Author : Fist_Author_Year_PM
4

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Keywords : ['sulphonylurea improve glycaemic control compare', 'randomise control trial', 'type diabete', 'submaximal dose', 'saxagliptin add', 'sulphonylurea', 'uptitration', 'patient']
Author : Fist_Author_Year_PM
4

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.

Keywords : ['randomised doubleblind placebocontrolle trial', 'exist antidiabete treatment', 'chronic kidney disease', 'type diabetes', 'empagliflozin add', 'safety', 'patient', 'efficacy']
Author : Fist_Author_Year_PM
4

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.

Keywords : ['randomise control trial', 'dapagliflozin metformin xr', 'type diabete', 'initial pharmacotherapy']
Author : Fist_Author_Year_PM
4

Diabetes Health, Residence & Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial.

Keywords : ['blind randomised placebo control trial', 'diabete health residence metabolism', 'dhrma study research', 'indian subcontinent', 'food', 'asians']
Author : Fist_Author_Year_PM
4

Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data.

Keywords : ['type diabetes mellitus', 'clinical trial datum', 'canagliflozincurrent status', 'treatment', 'focus']
Author : Fist_Author_Year_PM
4

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.

Keywords : ['onceweekly semaglutide versus daily canagliflozin', 'doubleblind phase randomise control trial', 'type diabetes sustain', 'safety', 'patient', 'metformin', 'efficacy', 'addon']
Author : Fist_Author_Year_PM
4

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.

Keywords : ['type diabetes mellitus', 'randomise control efficacy', 'dipeptidyl inhibitor saxagliptin', 'safety study', 'renal impairment', 'longterm treatment', 'patient']
Author : Fist_Author_Year_PM
4